Subscription Opens Today! Lenskart IPO GMP at 12%, Anchor Investors Bet Big ₹ 3,268 Cr Infusion- Should You Apply?
Lenskart IPO GMP: The much-awaited Lenskart IPO officially opened for public subscription today, October 31, 2025, with Lenskart IPO GMP trading at a 12% premium. Backed by SoftBank, ADIA, and Premji Invest, the Peyush Bansal-led eyewear unicorn raised a hefty ₹3,268 crore from 147 anchor investors on October 30 — a day before its public issue.
The Lenskart IPO GMP trend has been volatile this week, reflecting profit-booking sentiment and market-wide consolidation, despite the strong anchor backing.
What is the Latest Lenskart IPO GMP & How It Has Moved This Week?
While institutional participation remains strong, the Lenskart IPO GMP (grey market premium) slipped to ₹48 per share as of October 30, signaling cautious optimism among retail investors. With the upper price band set at ₹402, the grey market suggests an expected listing price of around ₹450, translating to a 12% premium.
The Lenskart IPO GMP has seen fluctuations over the past few days — mirroring investor sentiment in India’s primary market. After peaking at ₹120 on October 26, the premium has corrected steadily amid broader market volatility.
| Date | Lenskart IPO GMP | GMP Trend | Approx. Gain (%) |
|---|---|---|---|
| Oct 26 | ₹120 | Up | 29.85% |
| Oct 27 | ₹68 | Down | 16.92% |
| Oct 28 | ₹109 | Up | 27.11% |
| Oct 29 | ₹80 | Down | 19.90% |
| Oct 30 | ₹48 | Down | 11.94% |
Analysts note that while the GMP has cooled, this is not necessarily a red flag. Market experts believe that the correction stems from “valuation alignment” and profit booking in the grey market rather than a lack of confidence.
Also Read: Groww IPO GMP Around 11%, Valuation Soars to ₹16,000 Cr
Who Are the Key Anchor Investors in the Lenskart IPO?
Lenskart’s anchor round allocation on October 30 reflected massive institutional participation, both domestic and global. The company allotted 8.13 crore shares at ₹402 apiece, with 35.3% of the anchor book going to Indian mutual funds.
| Top Anchor Investors | Allocation (%) |
|---|---|
| T. Rowe Price International Discovery Fund | 3.11% |
| SBI Focused Fund | 3.06% |
| Government of Singapore | 2.97% |
| Goldman Sachs India Equity Portfolio | 2.60% |
| HDFC MF, ICICI Pru MF, Axis MF, Kotak MF | Combined 15%+ |
Other notable investors included BlackRock, Nomura, Fidelity, Steadview Capital, and Government Pension Fund Global. Insurance majors such as SBI Life, HDFC Life, and Tata AIA Life also joined the anchor book — highlighting solid institutional faith despite short-term GMP weakness.
What Does the Lenskart IPO Offer to Investors?
The ₹7,278 crore IPO consists of a fresh issue of ₹2,150 crore and an offer for sale (OFS) of 12.75 crore shares worth ₹5,128 crore. The offer will remain open from October 31 to November 4, 2025.
| Lenskart IPO Details | Information |
|---|---|
| IPO Size | ₹7,278 crore |
| Fresh Issue | ₹2,150 crore |
| OFS | ₹5,128 crore |
| Price Band | ₹382 – ₹402 per share |
| Market Lot | 37 shares |
| IPO Dates | Oct 31 – Nov 4, 2025 |
| Listing On | NSE, BSE |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Lead Managers | Kotak Mahindra Capital, Morgan Stanley, Citigroup, Avendus, Axis Capital, Intensive Fiscal Services |
Retail investors can apply for a minimum of one lot (37 shares), requiring an investment of about ₹14,874 at the upper price band. The proceeds from the fresh issue will primarily fund store expansion, cloud infrastructure, technology upgrades, and brand marketing initiatives.
Should You Apply for IPO Amid a Falling Lenskart IPO GMP?
Despite the Lenskart IPO GMP decline, analysts suggest the IPO remains attractive for long-term investors due to its robust fundamentals, expanding market share, and strong institutional support.
Retail investors should view the lower GMP as an opportunity for potential value entry, as it reduces overvaluation risk. Moreover, Lenskart’s digital-first growth strategy and global retail push position it well for sustained earnings growth.
Experts tracking the issue believe that listing gains may range between 8–12%, depending on subscription demand and market conditions during listing week.
Final Takeaway: Long-Term Vision Outweighs Short-Term GMP Fluctuations
The Lenskart IPO GMP may have softened, but investor sentiment remains firm thanks to the ₹3,268 crore anchor book led by top global funds. With strong brand recall, scalable operations, and deep-pocketed backers, Lenskart stands as one of the most promising consumer-tech listings on Dalal Street this year.
For investors, the takeaway is clear — while short-term GMP swings may create noise, Lenskart’s fundamentals and market leadership point toward long-term value creation.
Click Here to know more market & IPO related news and updates.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
